Periostin exhibits effects on epithelial cells and fibroblasts that may contribute to airway remodeling in asthma (Takayama et al., 2006; Sidhu et al., 2010) and may prove to be useful as a biomarker to identify those subjects most likely to give a positive clinical response to IL-13 antagonism. This evidence concerns the gene IL13 and asthma.